AAAAAA
Results: 1-25/31
Authors:
Sunkersett, MR
Grimsey, IM
Doughty, SW
Osborn, JC
York, P
Rowe, RC
Citation: Mr. Sunkersett et al., The changes in surface energetics with relative humidity of carbamazepine and paracetamol as measured by inverse gas chromatography, EUR J PH SC, 13(2), 2001, pp. 219-225
Authors:
Bristow, S
Shekunov, T
Shekunov, BY
York, P
Citation: S. Bristow et al., Analysis of the supersaturation and precipitation process with supercritical CO2, J SUPERCR F, 21(3), 2001, pp. 257-271
Authors:
Bristow, S
Shekunov, BY
York, P
Citation: S. Bristow et al., Solubility analysis of drug compounds in supercritical carbon dioxide using static and dynamic extraction systems, IND ENG RES, 40(7), 2001, pp. 1732-1739
Authors:
Tong, HHY
Shekunov, BY
York, P
Chow, AHL
Citation: Hhy. Tong et al., Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids, PHARM RES, 18(6), 2001, pp. 852-858
Authors:
Kordikowski, A
Shekunov, T
York, P
Citation: A. Kordikowski et al., Polymorph control of sulfathiazole in supercritical CO2, PHARM RES, 18(5), 2001, pp. 682-688
Authors:
Jouyban-Gharamaleki, A
York, P
Hanna, M
Clark, BJ
Citation: A. Jouyban-gharamaleki et al., Solubility prediction of salmeterol xinafoate in water-dioxane mixtures, INT J PHARM, 216(1-2), 2001, pp. 33-41
Authors:
Edwards, AD
Shekunov, BY
Forbes, RT
Grossmann, JG
York, P
Citation: Ad. Edwards et al., Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine, J PHARM SCI, 90(8), 2001, pp. 1106-1114
Authors:
Edwards, AD
Shekunov, BY
Kordikowski, A
Forbes, RT
York, P
Citation: Ad. Edwards et al., Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS (TM)), J PHARM SCI, 90(8), 2001, pp. 1115-1124
Authors:
Rehman, M
Shekunov, BY
York, P
Colthorpe, P
Citation: M. Rehman et al., Solubility and precipitation of nicotinic acid in supercritical carbon dioxide, J PHARM SCI, 90(10), 2001, pp. 1570-1582
Authors:
Shekunov, BY
Baldyga, J
York, P
Citation: By. Shekunov et al., Particle formation by mixing with supercritical antisolvent at high Reynolds numbers, CHEM ENG SC, 56(7), 2001, pp. 2421-2433
Authors:
Tservistas, M
Levy, MS
Lo-Yim, MYA
O'Kennedy, RD
York, P
Humphrey, GO
Hoare, M
Citation: M. Tservistas et al., The formation of plasmid DNA loaded pharmaceutical powders using supercritical fluid technology, BIOTECH BIO, 72(1), 2001, pp. 12-18
Authors:
Raghavan, SL
Ristic, RI
Sheen, DB
Sherwood, JN
Trowbridge, L
York, P
Citation: Sl. Raghavan et al., Morphology of crystals of alpha-lactose hydrate grown from aqueous solution, J PHYS CH B, 104(51), 2000, pp. 12256-12262
Authors:
Moshashaee, S
Bisrat, M
Forbes, RT
Nyqvist, H
York, P
Citation: S. Moshashaee et al., Supercritical fluid processing of proteins I: Lysozyme precipitation from organic solution, EUR J PH SC, 11(3), 2000, pp. 239-245
Authors:
Crowley, KJ
Forbes, RT
York, P
Nyqvist, H
Camber, O
Citation: Kj. Crowley et al., Drug-fatty acid salt with wax-like properties employed as binder in melt granulation, INT J PHARM, 211(1-2), 2000, pp. 9-17
Authors:
York, P
Citation: P. York, Supercritical fluids ease drug delivery, MANUF CHEM, 71(6), 2000, pp. 26
Authors:
Crowley, KJ
Forbes, RT
York, P
Apperley, DC
Nyqvist, H
Camber, O
Citation: Kj. Crowley et al., Characterization of oleic acid and propranolol oleate mesomorphism using C-13 solid-state nuclear magnetic resonance spectroscopy (SSNMR), J PHARM SCI, 89(10), 2000, pp. 1286-1295
Authors:
Shekunov, BY
York, P
Citation: By. Shekunov et P. York, Crystallization processes in pharmaceutical technology and drug delivery design, J CRYST GR, 211(1-4), 2000, pp. 122-136
Authors:
Beach, S
Latham, D
Sidgwick, C
Hanna, M
York, P
Citation: S. Beach et al., Control of the physical form of salmeterol xinofoate, ORG PROC R, 3(5), 1999, pp. 370-376
Authors:
Faure, A
Grimsey, IM
Rowe, RC
York, P
Cliff, MJ
Citation: A. Faure et al., Applicability of a scale-up methodology for wet granulation processes in Collette Gral high shear mixer-granulators, EUR J PH SC, 8(2), 1999, pp. 85-93
Authors:
Palakodaty, S
York, P
Citation: S. Palakodaty et P. York, Phase behavioral effects on particle formation processes using supercritical fluids, PHARM RES, 16(7), 1999, pp. 976-985
Authors:
Branchu, S
Forbes, RT
York, P
Nyqvist, H
Citation: S. Branchu et al., A central composite design to investigate the thermal stabilization of lysozyme, PHARM RES, 16(5), 1999, pp. 702-708
Authors:
Grimsey, IM
Sunkersett, M
Osborn, JC
York, P
Rowe, RC
Citation: Im. Grimsey et al., Interpretation of the differences in the surface energetics of two opticalforms of mannitol by inverse gas chromatography and molecular modelling, INT J PHARM, 191(1), 1999, pp. 43-50
Authors:
Branchu, S
Forbes, RT
York, P
Petren, S
Nyqvist, H
Camber, O
Citation: S. Branchu et al., Hydroxypropyl-beta-cyclodextrin inhibits spray-drying-induced inactivationof beta-galactosidase, J PHARM SCI, 88(9), 1999, pp. 905-911
Authors:
Kordikowski, A
York, P
Latham, D
Citation: A. Kordikowski et al., Resolution of ephedrine in supercritical CO2: A novel technique for the separation of chiral drugs, J PHARM SCI, 88(8), 1999, pp. 786-791
Authors:
Crowley, KJ
Forbes, RT
York, P
Nyqvist, H
Camber, O
Citation: Kj. Crowley et al., Oleate salt formation and mesomorphic behavior in the propranolol oleic acid binary system, J PHARM SCI, 88(6), 1999, pp. 586-591